留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

张莉敏,  陈宇峰,  战莹,  武晓丹,  周玉虹

downloadPDF
文章导航 > 药学实践与服务  > 2019 >  37(2): 141-145
张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹. 合生元益生菌治疗自发性高血压相关机制的代谢组学研究[J]. 药学实践与服务, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
引用本文: 张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹. 合生元益生菌治疗自发性高血压相关机制的代谢组学研究[J]. 药学实践与服务, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
shu
ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
Citation: ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
shu

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008
  • 1.

    复旦大学附属华东医院, 上海 200050

  • 2.

    原沈阳军区总医院, 辽宁 沈阳 110016

  • 3.

    沈阳药科大学药学院, 辽宁 沈阳 110016

基金项目: 辽宁省自然科学基金（20170540954）

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

  • 1.

    Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China

  • 2.

    General Hospital of Shenyang Military Area Command, Shenyang 110016, China

  • 3.

    School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

  • 摘要: 目的 应用代谢组学相关技术，从表观水平探索合生元制剂通过调节肠道菌群达到降压效应的可能作用机制。 方法 将14只自发性高血压大鼠随机分为2组，模型组和治疗组各7只，另取7只Wistar Kyoto大鼠作为对照组，采用超高效液相色谱-四级杆飞行时间串联质谱（UHPLC-Q-TOF/MS）技术对对照组、原发性高血压模型组和合生元制剂治疗组的大鼠模型回肠段进行代谢组学分析，筛选合生元制剂治疗自发性高血压的潜在生物学标志物。 结果 通过对代谢组学的分析，确定了对照组与模型组之间具有显著差异的27种代谢物。在这些代谢物中，与模型组相比，治疗组中溶血磷脂酰乙醇胺（LysoPE）和磷脂酰胆碱（PC）可以显著被重新调节。 结论 合生元制剂可以通过改变肠道微生物群的结构，调节LysoPE和PC相关信号通路，进而改善自发性高血压状态；代谢组学有助于从分子水平理解自发性高血压发病机制及合生元制剂的降压机制。
    Abstract: Objective To explore the possible mechanism of synergistic effect of synbiotic preparations by regulating intestinal flora to achieve antihypertensive effect by the metabolomics-related techniques. Methods Fourteen spontaneously hypertensive rats were randomly divided into two groups,7 rats in each of the model group and the treatment group,and another 7 Wistar Kyoto rats were used as the control group.Ileum metabolic profiling among the control group,Spontaneous hypertension model group and symbiotic treatment group were analyzed by ultra-high performance liquid chromatography coupled with tandem quadrupole time of flight mass spectrometry (UHPLC-Q-TOF MS).The potential biomarkers for the treatment of spontaneous hypertension were selected. Results In additional,27 metabolites with significant differences between the control and model group were identified by analysis of metabonomics.Among these metabolites,LysoPE and PC could be significantly re-regulated in the treatment group,compared with the model group. Conclusion Synbiotics could improve the status of spontaneous hypertension by changing the structure of the intestinal microbiota,regulating LysoPE and PC-related signaling pathways.Metabolomics could help to understand the pathogenesis of essential hypertension and the hypotensive mechanism of synbiotics at the molecular level.
  • [1] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
    [2] ZHENG Y,YU Alexander D,et al. Metabolomics and incident hypertension among blacks:the atherosclerosis risk in communities study[J]. Hypertension,2013,62(2):398-403.
    [3] YANG T,SANTISTEBAN M M,RODRIGUEZ V,et al. Gut dysbiosis is linked to hypertension[J].Hypertension,2015,65(6):1331-1340.
    [4] NICHOLSON J K,LINDON J C,HOLMES E.Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
    [5] SCHNACKENBERG L K B R. Monitoringthe health to disease continuumwith global metabolicprofilingandsystemsbiology[J]. Pharmacogenomics,2006,7(7):1077-1086.
    [6] AUSTDAL M,TANGERAS L H,SKRASTAD R B,et al. First trimester urine and serum metabolomics for prediction of preeclampsia and festational hypertension:a prospective screening study[J].Int J Mol Sci,2015,16(9):21520-21538.
    [7] RYU S B.Phospholipid-derived signaling mediated by phospholipase A in plants[J]. Trends Plant Sci,2004,9(5):229-235.
    [8] ROCK C O,JACKOWSKI S,CRONAN J E,et al.Lipid metabolism in prokaryotes[J]. Biochem Lip Lipoprot Membr, 1996:35-74.
    [9] ZHAO Q,LI X M,LIU H N,et al. Metabolic map of osthole and its effect on lipids[J]. Xenobiotica. 2018,48(3):285-299.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3147
  • HTML全文浏览量:  419
  • PDF下载量:  334
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-08-03
  • 修回日期:  2018-11-30

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008
  • 1. 复旦大学附属华东医院, 上海 200050
  • 2. 原沈阳军区总医院, 辽宁 沈阳 110016
  • 3. 沈阳药科大学药学院, 辽宁 沈阳 110016
    • 基金项目:  辽宁省自然科学基金（20170540954）
  • 收稿日期: 2018-08-03
  • 修回日期: 2018-11-30

摘要: 目的 应用代谢组学相关技术，从表观水平探索合生元制剂通过调节肠道菌群达到降压效应的可能作用机制。 方法 将14只自发性高血压大鼠随机分为2组，模型组和治疗组各7只，另取7只Wistar Kyoto大鼠作为对照组，采用超高效液相色谱-四级杆飞行时间串联质谱（UHPLC-Q-TOF/MS）技术对对照组、原发性高血压模型组和合生元制剂治疗组的大鼠模型回肠段进行代谢组学分析，筛选合生元制剂治疗自发性高血压的潜在生物学标志物。 结果 通过对代谢组学的分析，确定了对照组与模型组之间具有显著差异的27种代谢物。在这些代谢物中，与模型组相比，治疗组中溶血磷脂酰乙醇胺（LysoPE）和磷脂酰胆碱（PC）可以显著被重新调节。 结论 合生元制剂可以通过改变肠道微生物群的结构，调节LysoPE和PC相关信号通路，进而改善自发性高血压状态；代谢组学有助于从分子水平理解自发性高血压发病机制及合生元制剂的降压机制。

English Abstract

张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹. 合生元益生菌治疗自发性高血压相关机制的代谢组学研究[J]. 药学实践与服务, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
引用本文: 张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹. 合生元益生菌治疗自发性高血压相关机制的代谢组学研究[J]. 药学实践与服务, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
shu
ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
Citation: ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008
shu

    全文HTML

参考文献 (9)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计